---
title: "Aethlon Medical Raises ~$4.0 Million in Registered Offering Priced at $0.71; Maxim Group as Agent"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292050279.md"
description: "Aethlon Medical completed a registered public offering of common shares and warrants priced at $0.71 per share, raising approximately $4.0 million in gross proceeds. Maxim Group acted as the placement agent. The transaction included 263,000 common shares and up to 11,003,018 underlying shares via warrants. Proceeds are intended for general corporate purposes and working capital. The company entered into lock-up agreements with officers, directors, and investors."
datetime: "2026-07-08T10:03:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292050279.md)
  - [en](https://longbridge.com/en/news/292050279.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292050279.md)
generator: "portal-rs"
---

# Aethlon Medical Raises ~$4.0 Million in Registered Offering Priced at $0.71; Maxim Group as Agent

Aethlon Medical completed a registered public offering priced at $0.71 per share and accompanying warrant, entering a Securities Purchase Agreement with investors and a Placement Agency Agreement with Maxim Group. The transaction included 263,000 common shares, common and pre-funded warrants totaling up to 11,003,018 underlying shares, and yielded approximately $4.0 million in gross proceeds and about $3.335 million in net proceeds. Common warrants carry a $0.71 exercise price, exercisable upon stockholder approval or immediately if pricing conditions are met. The company agreed to a 90-day issuance lock-up, a one-year restriction on variable-rate deals without Maxim's consent, and 90-day lock-ups by officers and directors.

**Agreement 1: Aethlon Medical Prices $4.0 Million Registered Offering at $0.71 With Warrants**

-   **Agreement type**: Securities Purchase Agreement for registered equity offering with warrants
-   **Counterparty**: Certain investors
-   **Signed / Effective**: Jul 06 2026 / Jul 07 2026
-   **Duration / Termination**: At will
-   **Reason**: Raise working capital for general corporate purposes

**Agreement 2: Aethlon Medical Engages Maxim Group as Placement Agent for $4.0 Million Offering**

-   **Agreement type**: Placement Agency Agreement for registered offering
-   **Counterparty**: Maxim Group
-   **Signed / Effective**: Jul 06 2026 / Jul 06 2026
-   **Duration / Termination**: At will
-   **Reason**: Facilitate capital raise through a public offering

Original SEC Filing: AETHLON MEDICAL INC \[ AEMD \] - 8-K - Jul. 07, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [AEMD.US](https://longbridge.com/en/quote/AEMD.US.md)

## Related News & Research

- [Aethlon Medical: Pre-Revenue Status, Ongoing Cash Burn, and Early Hemopurifier Progress Support Balanced Risk/Reward and Hold Rating](https://longbridge.com/en/news/296262387.md)
- [Aethlon Medical (AEMD) Fiscal Q1 2027 Earnings Call: Oncology Trial Enters Final Cohort](https://longbridge.com/en/news/295899977.md)
- [Gaxos.ai closes warrant exercise at reduced $1.2 per share](https://longbridge.com/en/news/296140843.md)
- [Guardian Metal Resources PLC Announces Warrant Exercise | GMTL Stock News](https://longbridge.com/en/news/296090846.md)
- [REG - Sareum Holdings PLC - Exercise of Warrants](https://longbridge.com/en/news/296362927.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**